Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
5-day change
1st Jan Change
5,543
JPY
-0.66%
+0.71%
-18.37%
Kobayashi Pharmaceutical Co., Ltd. completed the acquisition of True Nature Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) agreed to acquire True Nature Co., Ltd on June 20, 2018. Kobayashi Pharmaceutical will acquire all shares of True Nature Co., Ltd, post which True Nature Co., Ltd will operate as a subsidiary of Kobayashi Pharmaceutical. True Nature Co., Ltd reported revenues of ¥346 million in the year ended December 31, 2017. The transaction is expected to complete on July 18, 2018.
Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) completed the acquisition of True Nature Co., Ltd in July 2018.
A second Kobayashi Pharma Japan factory inspected over deaths
Mar. 31
RE
Kobayashi factory searched over deaths possibly linked to supplements
Mar. 29
RE
Kobayashi Pharmaceutical Recalls 'Beni-Koji' Supplement Following Report of Death, Kidney Damage
Mar. 26
MT
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 7, 2023.
Nov. 07
CI
Kobayashi Pharmaceutical Co., Ltd's Equity Buyback announced on November 7, 2023, has closed with 1,924,600 shares, for ¥11,999.88 million.
Nov. 07
CI
Kobayashi Pharmaceutical Co., Ltd. acquired Focus Consumer Healthcare, LLC.
23-10-06
CI
Kobayashi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-10
CI
Organ Technologies Inc announced that it has received funding from Kobayashi Pharmaceutical Co., Ltd.
23-02-09
CI
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 1, 2022.
22-11-01
CI
Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback announced on November 1, 2022, has closed with 1,150,602 shares, representing 1.49% for ¥9,991.92 million.
22-11-01
CI
Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,265,800 shares, representing 1.64% for ¥9,999.82 million.
22-11-01
CI
Kobayashi Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
22-10-31
CI
Kobayashi Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Full Year 2022
22-08-04
CI
UBS Adjusts Kobayashi Pharmaceutical's Price Target to 12,600 Yen From 13,100 Yen, Keeps at Buy
22-03-03
MT
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 28, 2021.
22-02-14
CI
Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback announced on October 28, 2021, has expired with 883,300 shares, representing 1.13% for ¥7,999.54 million.
22-02-09
CI
Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,000,000 shares, representing 1.28% for ?8,000 million.
21-10-28
CI
Kobayashi Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
21-10-27
CI
Kobayashi Pharmaceutical Co., Ltd. acquired Alva-Amco Pharmacal Companies, Inc. from Trusts all owned by the founder's family for approximately $110 million.
20-09-29
CI
Kobayashi Pharmaceutical Co., Ltd.(TSE:4967) added to S&P Japan Mid Cap 100
20-06-22
CI
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 31, 2019.
19-05-21
CI
Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 31, 2019 has expired with 909,500 shares for ¥7,999.28 million.
19-05-15
CI
Kobayashi Pharmaceutical Co., Ltd. acquired Meitanhonpo.Co.,Ltd.
19-05-13
CI
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 31, 2019.
19-04-01
CI
Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,300,000 shares, representing 1.64% for ¥8,000 million.
19-01-31
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
More about the company
Last Close Price
5,543
JPY
Average target price
8,182
JPY
Spread / Average Target
+47.60%
Consensus
1st Jan change
Capi.
-18.37% 2.61B +9.64% 381B +8.05% 129B -16.39% 62.59B +0.09% 52.86B -12.35% 36.11B +3.17% 33.57B +9.80% 17.29B +7.68% 14.75B -9.06% 10.82B
Other Personal Products
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
KOBAYASHI PHARMACEUTICAL CO., LTD. 
